Journal of Clinical Endocrinology & Metabolism, Vol 75, 1250-1254, Copyright © 1992 by Endocrine Society

ARTICLES

Effects of unopposed conjugated equine estrogen on lipoprotein composition and apolipoprotein-E distribution

RA Muesing, VT Miller, JC LaRosa, DB Stoy and EA Phillips
Department of Medicine, George Washington University Medical Center, Washington, D.C. 20037.

Administration of conjugated equine estrogen to 31 postmenopausal women for 3 months produced 14.6% and 9.4% decreases in low density lipoprotein cholesterol (LDL-C) and apolipoprotein-B (apoB), and 11.5%, 12.7%, and 9.6% increases in high density lipoprotein cholesterol (HDL- C), apoA-I and apoA-II, respectively. Phospholipids of HDL2 and HDL3 were increased 57.9% and 19.3%, respectively, while relatively small increases in cholesterol of the two subfractions were not significant. Compositions of LDL and HDL and its subfractions were altered substantially with estrogen treatment. The proportion of LDL triglyceride to LDL-C was increased. The phospholipid content in both the HDL2 and HDL3 subfractions (compared to cholesterol) was increased significantly (34.8% and 10.7%, respectively), while the triglyceride content was increased only in the HDL2 subfraction (43.6%). Estrogen use also caused a 9.1% reduction in total apoE levels and a redistribution of apoE to the very low density lipoprotein (VLDL) from the LDL plus HDL fraction, resulting in a significant 19.5% decrease in apoE in the LDL plus HDL fraction. Changes in apoE in the VLDL fraction were associated positively with changes in the cholesterol levels of the VLDL fraction and inversely with changes in LDL-C and apoB levels, while changes in apoE in the LDL plus HDL fraction were associated positively with changes in the levels of HDL-C. Thus, estrogen causes alterations in lipoproteins that could potentially affect their metabolism and/or function.

This article has been cited by other articles:

				Y.-H. Suh and F. Checler Amyloid Precursor Protein, Presenilins, and alpha -Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease Pharmacol. Rev., September 1, 2002; 54(3): 469 - 525. [Abstract] [Full Text] [PDF]

				R. S. Turner Alzheimer's Disease in Man and Transgenic Mice : Females at Higher Risk Am. J. Pathol., March 1, 2001; 158(3): 797 - 801. [Full Text] [PDF]

				E. Lanza, M. R. Forman, E. J. Johnson, R. A. Muesing, B. I. Graubard, and G. R. Beecher alpha -Tocopherol Concentrations in Plasma but not in Lipoproteins Fluctuate during the Menstrual Cycle in Healthy Premenopausal Women J. Nutr., July 1, 1998; 128(7): 1150 - 1155. [Abstract] [Full Text] [PDF]

				J. M. Hodgson, I. B. Puddey, L. J. Beilin, T. A. Mori, and K. D. Croft Supplementation with Isoflavonoid Phytoestrogens Does Not Alter Serum Lipid Concentrations: A Randomized Controlled Trial in Humans J. Nutr., April 1, 1998; 128(4): 728 - 732. [Abstract] [Full Text]